Larimar Therapeutics Inc.

2.64
-0.39 (-12.87%)
At close: Mar 03, 2025, 3:59 PM
2.79
5.68%
After-hours: Mar 03, 2025, 07:53 PM EST

Larimar Therapeutics Ratios Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11
PE Ratio -5.41 -3.11 -3.68 -6.01 -5.31 -2.6 -2.44 -1.5 -2.27 -24.45 -36.8 -37.19 -39.23
PEG Ratio 0.15 0.06 0.21 -0.14 0.06 -6.57 0.23 0.06 -0.02 -0.19 -16.82 -6.84 n/a
PS Ratio n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
PB Ratio 2.44 0.96 2.88 2.84 -176.84 1.71 1.62 0.71 1.00 8.56 14.65 64.07 n/a
P/FCF Ratio -5.94 -3.85 -4.36 -6.02 -5.39 -3.09 -2.89 -1.65 -2.8 -31.6 -34.36 -37.98 -41.93
P/OCF Ratio -5.97 -3.86 -4.4 -6.03 -5.41 -3.1 -2.89 -1.67 -2.83 -31.66 -34.4 -37.98 -42.05
OCF/S Ratio n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio 0.07 0.05 0.09 0.07 -0.14 0.22 0.26 0.03 0.04 0.07 n/a n/a n/a
Quick Ratio 9.49 11.28 8.19 10.90 0.27 9.12 14.39 13.23 11.37 16.98 12.82 3.52 n/a
Current Ratio 9.49 11.28 8.16 10.89 0.81 9.12 14.39 13.23 11.37 16.98 12.82 3.52 n/a
Asset Turnover n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Interest Coverage n/a n/a n/a n/a n/a n/a -55.48 -164.62 -91.58 40.84 n/a -142.18 n/a
Return on Equity (ROE) -0.45 -0.31 -0.78 -0.47 33.33 -0.66 -0.67 -0.48 -0.44 -0.35 -0.4 -1.72 n/a
Return on Assets (ROA) -0.39 -0.27 -0.64 -0.4 -4.45 -0.5 -0.49 -0.44 -0.39 -0.31 -0.37 -1.26 n/a
Return on Capital (ROIC) -0.48 -0.32 -0.72 -0.45 33.45 -0.58 -0.55 -0.47 -0.43 -0.32 -0.39 -1.71 n/a
Dividend Yield n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a